|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Peroxisome proliferator activated receptor-gamma agonist rosiglitazone reduces circulating platelet activity in patients without diabetes mellitus who have coronary artery disease 显示文摘 | SIDHU JS COVAN D TOOZE JA | 2004 | Am Heart J2004，107，6： | 1 |
| 2 | Ameliorative action of melatonin on oxidative damage induced by atrazine toxicity in rat erythrocytes 显示文摘 | Bhatti JS Sidhu IP Bhatti GK | 2011 | Mol Cell Biochem2011，353，12： | 1 |
| 3 | The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients显示文摘 | Sidhu JS Cowan D Kaski JC | 2003 | J Am Coll Cardiol2003，42，10： | 1 |
| 4 | Transgenic mouse model of ventricular preexeitation and atrioventrieular reentrant taehycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome 显示文摘 | Sidhu JS Rajawat YS Rami TG | 2005 | Circulation2005，111，1： | 1 |
| 5 | Lumbosacral plexus avulsion with pelvic fra- ctures显示文摘 | Sidhu JS Dhillon MK | 1991 | Injury1991，22，2： | 1 |
| 6 | The effects of rosiglitazone, a PPARgamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients显示文摘 | Sidhu JS Cowen D Kaski JC | 2003 | J Am Coll Cardiol2003，42，10： | 1 |
| 7 | Peroxisome proliferator-activated receptor- agonist rosiglitazone reduces circulating platelet activity in patients without diabetes mellitus who have coronary artery disease 显示文摘 | Sidhu JS Cowan D Tooze JA | 2004 | Am Heart J2004，147，6： | 1 |
| 8 | Hip fracture in the elderly ; a cross-national study显示文摘 | Sidhu JS Ddhl | 1991 | Osteoporosis Int1991，1，4： | 1 |
| 9 | Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus 显示文摘 | Sidhu JS Kaposzta Z Markus HS | 2004 | Arterioscler Thromb Vasc Biol2004，24，5： | 1 |
| 10 | Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus 显示文摘 | Sidhu JS Cowan D Kaski JC | 2004 | Am J Cardiol2004，94，2： | 1 |
| 11 | Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus显示文摘 | Sidhu JS Cowan D Kaski JC | 2004 | American Journal of Cardiology2004，94，2： | 1 |
| 12 | Effect of rosiglitazone on common carotid inti- ma - media thickness progression in coronary artery disease patients without diabetes mellitus 显示文摘 | Sidhu JS Kaposzta Z Markus HS | 2004 | Arteriosclerosis Thrombosis & Vascular Biology2004，24，5： | 1 |
| 13 | The effects of rosiglitazone,a peroxisome proliferator-activated receptor-gamma agonist,on markers of endothelial cell activation,C-reactive protein,and fibrinogen levels in non-diabetic coronary artery diseage patents显示文摘 | Cowan D Kaski JC | 2003 | J Am Coll Cardiol2003，42，10： | 1 |
| 14 | Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus显示文摘 | Sidhu JS Kaposzta Z Markus HS | 2004 | Arterioscler Thromb Vasc Bioh2004，24，5： | 1 |
| 15 | Effect of rosiglitazone on common carotid intima - media thickness progression in coronary artery disease patients without diabetes mellitus 显示文摘 | Sidhu JS Kaposzta Z Markus HS | 2004 | Arteriosclerosis Thrombosis & Vascular Biology2004，24，5： | 1 |
| 16 | Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome显示文摘 | Sidhu JS Rajawat YS Rami TG | 2005 | Circulation2005，111，： | 1 |
| 17 | Effects of rosiglitazone on endothelial function in men with coronary artery disease without diabetes mellitus 显示文摘 | Sidhu JS Cowan D Kaski JC | 2004 | Am J Cardiol2004，94，2： | 1 |
| 18 | Platelet-derived Growth factor stimulatesprotein kinase A through mitogen-activated protein kinase-dependent pathway in humanarterial smooth muscle cells 显示文摘 | Graves LM Bornfeldt KE Sidhu JS | 1996 | J Biol Chem1996，271，： | 1 |
| 19 | Investigation of multiple dose citalopram on the pharmacokinetics and pharmacodynamics of racemic warfarin显示文摘 | Priskorn M Sidhu JS Larsen F | 1997 | Br J Clin Pharmacol1997，44，2： | 1 |
| 20 | Serum molecular signatures of weight change during early breast cancer chemotherapy显示文摘 | Keun HC Sidhu J Pchejetski D Lewis JS Marconell H Patterson M | | 0，，21： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员